共 50 条
Clinically relevant improvements in asthma-related quality of life in patients receiving omalizumab as add-on therapy
被引:1
|作者:
Busse, W
Fox, H
Surrey, K
Maykut, R
Reisner, C
机构:
[1] Univ Wisconsin, Dept Med, Madison, WI 53706 USA
[2] Novartis Horsham Res Ctr, Horsham, W Sussex, England
[3] Novartis Pharmaceut Corp, E Hanover, NJ USA
关键词:
D O I:
10.1016/j.jaci.2005.12.033
中图分类号:
R392 [医学免疫学];
学科分类号:
100102 ;
摘要:
30
引用
收藏
页码:S8 / S8
页数:1
相关论文